[关于喘中乙氨基酸异质性的研究进展]
Yan Chen1,2,3, Song-Min Ying4,2, Chao Zhang5,2
1Institute of Respiratory Diseases, Zhejiang University, Hangzhou 310030, China.
Sheng li xue bao : [Acta physiologica Sinica]
|August 28, 2024
概括
乙氨基基基异质性在喘的发展和严重性中起着关键作用. 了解这些差异可能会导致个性化喘治疗,针对特定的乙氨基基酸作用.
科学领域:
- 免疫学 免疫学 免疫学
- 肺部病理学 肺部病理学
- 过敏研究 研究过敏
背景情况:
- 喘是一种慢性呼吸道炎症疾病.
- 过敏原引发了超过一半的喘病例.
- 乙氨基酸的积累与喘的严重程度相关.
研究的目的:
- 审查关于喘中乙酸氨基基异质性的研究.
- 在喘病原发生过程中探讨埃奥西诺菲尔的作用.
- 建议未来准确治疗喘的方向.
主要方法:
- 关于近期埃索诺菲尔和喘研究的文献综述.
- 分析关于乙酸性异质性的研究.
- 综合与喘向治疗相关的发现.
主要成果:
- 在喘的发病和进展中,乙氨基基基的异质性至关重要.
- 特定的乙素基组对呼吸道炎症有不同的贡献.
- 目前的研究突出了针对性治疗埃索诺菲尔驱动的喘.
结论:
- 乙氨基基基异质性是喘的一个重要因素.
- 向特定的乙酸性特征提供了个性化的治疗潜力.
- 未来的研究应该专注于根据乙氨基基基形状量身定制喘疗法.
更多相关视频
08:44Identification and Characterization of Immunogenic RNA Species in HDM Allergens that Modulate Eosinophilic Lung Inflammation
Published on: May 30, 2020
6.1K
09:58A Reversible, Non-invasive Method for Airway Resistance Measurements and Bronchoalveolar Lavage Fluid Sampling in Mice
Published on: April 13, 2010
22.4K
相关概念视频
Asthma-II: Pathophysiology and Classification
2.6K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.6K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
254
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
254
Asthma: Pathogenesis and Management
376
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
376
Asthma-I: Introduction
2.6K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.6K
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K
